Invitation to investor meeting at ESTRO in Copenhagen
STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a meeting in conjunction with ESTRO 2022 in Copenhagen, Denmark.
The investor meeting will be held on Saturday, May 7, at 9:30 – 11:30 a.m. local time, at Bella Center Copenhagen (the venue of ESTRO 2022). Speakers will include Gustaf Salford, Elekta’s President and CEO, Maurits Wolleswinkel, Chief Product Officer as well as other leaders of Elekta. To attend, please register via https://events.elekta.com/elekta-investor-meeting-at-estro by April 28.
Elekta will also host a Linac Spotlight event on Friday, May 6 where customers from across Europe describe how they are experiencing the difference and enhancing their clinical practice with Elekta.
Welcome!
# # #
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: [email protected]
Time zone: CET (Central European Time)
Kira Haapanen, IR Manager
Tel. +46 73 719 46 22, e-mail: [email protected]
Time zone: CET (Central European Time)
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope.
Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.